EMBARQ

Serial Number 87524619
606

Registration Progress

Application Filed
Jul 12, 2017
Under Examination
Nov 28, 2017
Approved for Publication
Oct 3, 2017
Published for Opposition
Oct 3, 2017
Registered

Trademark Image

EMBARQ

Basic Information

Serial Number
87524619
Filing Date
July 12, 2017
Published for Opposition
October 3, 2017
Abandonment Date
July 2, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 2, 2018
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
980 Great West Road
Brentford, Middlesex TW89GS
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Brentford, Middlesex GB

Glaxo Group Limited

Owner at Publication
99
Brentford, Middlesex GB

Legal Representation

Attorney
Angela L. Wilson, Christopher M. Hanes, Terence A. Dixon and Charles M. Atkinson

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jul 2, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 2, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 28, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 3, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 3, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 13, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 22, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 18, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 18, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 15, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
(Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005